HC
DGX icon

HNP Capital’s Quest Diagnostics DGX Stock Holding History

HNP Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,400
Closed -$219K – 130
2022
Q4 		$219K Buy
+1,400
New +$201K 0.06% 125
2022
Q1 		– Sell
-1,500
Closed -$260K – 158
2021
Q4 		$260K Buy
1,500
+100
+7% +$15.2K 0.06% 146
2021
Q3 		$203K Buy
+1,400
New +$205K 0.05% 152
2020
Q2 		– Sell
-4,134
Closed -$390K – 165
2020
Q1 		$390K Buy
+4,134
New +$428K 0.06% 170

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HNP Capital's DGX Position: Q1 2023 in Review

HNP Capital sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 1,400 shares — an estimated $219K sold.

HNP Capital first reported a position in DGX in Q1 2020 and held it in 4 quarters. The position peaked at $390K in Q1 2020. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

  • HNP Capital reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
  • HNP Capital sold 1,400 Quest Diagnostics shares in Q1 2023, an estimated $219K.
  • HNP Capital first reported a position in Quest Diagnostics in Q1 2020 and held it in 4 quarters.
  • HNP Capital's Quest Diagnostics position peaked at $390K in Q1 2020.
  • 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.